Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Deregulated cellular metabolism is a hallmark of cancer, often involving mitochondrial dysfunction.
• The tumor suppressor protein p53 is critical for maintaining genome integrity and has known roles in apoptosis.
• Recent research highlights p53's extra-nuclear functions, particularly its involvement in cellular energetics and metabolism.

Purpose of the Study:

• To review the multifaceted roles of wild-type and mutant p53 in regulating mitochondrial metabolism.
• To explore how p53 influences metabolic pathways relevant to cancer development and progression.
• To discuss the potential of targeting p53-mediated metabolic changes for cancer therapy.

Main Methods:

• Literature review of studies on p53, mitochondrial metabolism, and cancer.
• Analysis of research on p53 localization (nuclear vs. cytoplasmic) and its functional consequences.
• Synthesis of findings regarding the impact of wild-type and mutant p53 on metabolic pathways.

Main Results:

• Wild-type p53 regulates mitochondrial metabolism to preserve cellular homeostasis.
• Mutant p53 proteins often gain new functions, promoting metabolic alterations that drive cancer growth and metastasis.
• Cytoplasmic p53 influences key metabolic processes including autophagy, the pentose phosphate pathway, and fatty acid metabolism.

Conclusions:

• Both wild-type and mutant p53 are critical regulators of cellular and mitochondrial metabolism in normal and cancer cells.
• Understanding the mechanistic details of p53's metabolic control is essential for developing novel therapeutic strategies.
• Targeting p53-driven metabolic reprogramming holds promise for future cancer treatments.